PET/MR can be used to evaluate pulmonary lesions

03/5/2012 | (free registration)

Lesion characterization findings and tumor staging using PET/MR were similar to those of PET/CT in seven of 10 patients with likely or confirmed lung cancer, according to a German study. "The results justify further investigation of MR/PET in the assessment of pulmonary lesions, especially with respect to the broad spectrum of function of MR techniques," said Dr. Christina Schraml from Eberhard Karls University, Tübingen in Germany.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA